COMMUNIQUÉS West-GlobeNewswire

Vaxart to Host Conference Call on June 11 at 8:30 AM ET to Discuss Topline Results from Its Phase I Norovirus Trial
10/06/2025
SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery [...]
BioAegis Therapeutics Announces US Navy Contract to Support Phase 2 Study of Recombinant Human Gelsolin, for Inflammasome-Driven Decompression Sickness (DCS)
10/06/2025
Phase 2 proof-of-concept study for rhu-pGSN, a promising intervention across a spectrum of inflammatory diseases, to be studied as an intervention for the negative outcomes of decompression in SCUBA Divers NORTH [...]
ReflexMD Expands Digital Health Access Nationwide with Seamless Prescription Experience
10/06/2025
Telehealth Platform Offers Nationwide Access to Licensed Providers for Weight Management, Hair Loss, and Wellness Care From Home Claymont, June 10, 2025 (GLOBE NEWSWIRE) -- ReflexMD, a telehealth platform redefining [...]
argenx Presents New Efgartigimod Data at EULAR 2025 Highlighting Positive Phase 2 Proof-of-Concept Results in Myositis and Sjogren’s Disease
11/06/2025
ALKIVIA data demonstrate significant improvement in muscle strength and physical function in myositis patients treated with efgartigimod RHO data show efgartigimod achieved sustained reduction in autoantibodies and [...]
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
11/06/2025
Not for dissemination in the United States of America VANCOUVER, British Columbia, June 10, 2025 (GLOBE NEWSWIRE) -- Aja Health and Wellness Inc. ("Aja" or the "Company") (TSXV:Aja) announces that it is getting closer [...]
Enhance.MD Launches Nationwide Telehealth Expansion to Support Men’s Hormonal Health and Medically Supervised Weight Loss
11/06/2025
Virtual platform now offers licensed physician care for testosterone therapy, GLP-1 weight loss support, and men’s wellness programs across all 50 U.S. states San Diego, June 10, 2025 (GLOBE NEWSWIRE) -- Enhance.MD, a U [...]
PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
11/06/2025
Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare’s Updated Virtual Health Platform San Francisco, June 10, 2025 (GLOBE NEWSWIRE) -- PlushCare, a leading [...]
Cooper Aerobics Partners with Parker University
11/06/2025
Medical fitness test now available at two Parker locations DALLAS, June 10, 2025 (GLOBE NEWSWIRE) -- Cooper Wellness Strategies (CWS), a Cooper Aerobics company, announces a partnership with Parker University, bringing [...]
Quest PharmaTech Announces Opposition to OQPBIOM's Acquisition of AdBioTech
11/06/2025
EDMONTON, Alberta, June 10, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through [...]
Mochi Health Launches Enhanced Online Platform to Support Medical Weight Loss Patients Nationwide
11/06/2025
Updated Virtual Weight Loss Platform Expands Access to GLP-1 Support and Clinician-Guided Obesity Care Across All 50 States SAN FRANCISCO, June 10, 2025 (GLOBE NEWSWIRE) -- Mochi Health, a physician-founded telehealth [...]
NuggMD Now Serves All Eligible Medical Cannabis Patients Nationwide via Secure Telehealth Platform
11/06/2025
Trusted Telemedicine Platform for Medical Marijuana Expands Access Across 25+ States Where Legal Los Angeles, June 10, 2025 (GLOBE NEWSWIRE) -- NuggMD, the nation’s leading medical marijuana telehealth platform, is [...]
MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
10/06/2025
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today [...]
Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development
10/06/2025
NEW HAVEN, Conn., June 10, 2025 (GLOBE NEWSWIRE) -- Bexorg, Inc. , a pioneering techbio company working to decode the human brain and advance new therapies for central nervous system (CNS) disorders, today announced a [...]
PeterMD Announces Official Website Update Featuring Telemedicine Services for Men's Hormone Health and TRT Support
10/06/2025
National Platform Offers Secure Access to Physician-Led TRT and Hormone Health Consultations from Anywhere in the U.S. VERO BEACH, June 10, 2025 (GLOBE NEWSWIRE) -- PeterMD, a Florida-based men's health telemedicine [...]
XPro™ Reduces Amyloid and Enhances Behavior Post Traumatic Brain Injury in an Animal Model of Alzheimer’s Disease: Supported by Department of Defense
10/06/2025
XPro™ Treatment Post-TBI Prevents Short- and Long-Term Alzheimer’s-like Pathology in transgenic mice Boca Raton, Florida, June 10, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical- [...]
Inventiva Annonce la Nomination de Renée Aguiar-Lucander à son Conseil d’Administration
10/06/2025
Daix (France), New York City (New York, États-Unis), le 10 juin 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors
10/06/2025
Daix (France), New York City (New York, United States), June 10, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Celldex Announces Upcoming Presentations of Barzolvolimab Phase 2 Data in Chronic Spontaneous Urticaria at EAACI 2025 Congress
10/06/2025
Company to host webcast on Thursday, June 12 at 6:00 pm ET HAMPTON, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that data from the Company’s Phase 2 study of barzolvolimab in chronic [...]
Tilray Brands' Stockholders Approve Reverse Stock Split; Company Pauses Implementation as It Evaluates Timing and Stock Price
10/06/2025
NEW YORK and LEAMINGTON, Ontario, June 10, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of [...]

Pages